These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23143723)

  • 21. [Neuropsychological evaluation in a case of multiple sclerosis].
    Sanz de la Torre JC; Pérez-Ríos M
    Rev Neurol; 2000 Jun 16-30; 30(12):1161-5. PubMed ID: 10935244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive functioning in multiple sclerosis.
    Julian LJ
    Neurol Clin; 2011 May; 29(2):507-25. PubMed ID: 21439456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive and adaptive development of patients with tuberous sclerosis complex: a retrospective, longitudinal investigation.
    van Eeghen AM; Chu-Shore CJ; Pulsifer MB; Camposano SE; Thiele EA
    Epilepsy Behav; 2012 Jan; 23(1):10-5. PubMed ID: 22099526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of armodafinil on cognition in multiple sclerosis: a randomized, double-blind crossover pilot study.
    Bruce J; Hancock L; Roberg B; Brown A; Henkelman E; Lynch S
    Cogn Behav Neurol; 2012 Sep; 25(3):107-14. PubMed ID: 22960434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive impairment in multiple sclerosis.
    Hoffmann S; Tittgemeyer M; von Cramon DY
    Curr Opin Neurol; 2007 Jun; 20(3):275-80. PubMed ID: 17495620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Executive dysfunction and cognitive impairment in a large community-based sample with Multiple Sclerosis from New Zealand: a descriptive study.
    Drew M; Tippett LJ; Starkey NJ; Isler RB
    Arch Clin Neuropsychol; 2008 Jan; 23(1):1-19. PubMed ID: 17981008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis.
    Christodoulou C; Melville P; Scherl WF; Morgan T; MacAllister WS; Canfora DM; Berry SA; Krupp LB
    J Int Neuropsychol Soc; 2005 Sep; 11(5):614-9. PubMed ID: 16212689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
    Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
    Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fitness and cognitive processing speed in persons with multiple sclerosis: a cross-sectional investigation.
    Sandroff BM; Motl RW
    J Clin Exp Neuropsychol; 2012; 34(10):1041-52. PubMed ID: 22905722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the role of coping style as a moderator of fatigue and risk for future cognitive impairment in multiple sclerosis.
    Ukueberuwa DM; Arnett PA
    J Int Neuropsychol Soc; 2014 Aug; 20(7):751-5. PubMed ID: 24998987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological measures in clinical practice.
    Possa MF
    Neurol Sci; 2010 Nov; 31(Suppl 2):S219-22. PubMed ID: 20668898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
    Pepping M; Brunings J; Goldberg M
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):663-72. PubMed ID: 24314684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maturational Trajectory of Processing Speed Performance in Pediatric Multiple Sclerosis.
    Akbar N; Signori A; Amato MP; Sormani MP; Portaccio E; Niccolai C; Goretti B; Till C; Banwell B
    Dev Neuropsychol; 2017; 42(5):299-308. PubMed ID: 28872902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.
    Denney DR; Lynch SG; Parmenter BA
    J Neurol Sci; 2008 Apr; 267(1-2):129-36. PubMed ID: 17976653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline.
    Wallach AI; Waltz M; Casper TC; Aaen G; Belman A; Benson L; Chitnis T; Gorman M; Graves J; Harris Y; Lotze TE; Mar S; Moodley M; Ness JM; Rensel M; Rodriguez M; Rose JW; Schreiner T; Tillema JM; Waubant E; Weinstock-Guttman B; Charvet LE; Krupp LB
    Mult Scler; 2020 Dec; 26(14):1938-1947. PubMed ID: 31775571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.